CREFX | CREYX | CREFX / CREYX | |
Total Expense Ratio | 0.75 | 0.86 | 87% |
Annual Report Gross Expense Ratio | 0.75 | 0.86 | 87% |
Fund Existence | 8 years | 8 years | - |
Gain YTD | 5.114 | -2.100 | -244% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.03B | 156M | 5,146% |
Annual Yield % from dividends | 2.58 | 2.60 | 99% |
Returns for 1 year | 11.68 | 2.47 | 472% |
Returns for 3 years | 12.84 | -15.98 | -80% |
Returns for 5 years | 38.61 | -9.04 | -427% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MBGFX | 20.89 | 0.22 | +1.06% |
MassMutual Blue Chip Growth R4 | |||
WCMVX | 18.28 | 0.09 | +0.49% |
WCM Focused International Equity Ins | |||
IJMIX | 16.64 | 0.07 | +0.42% |
VY® JPMorgan Mid Cap Value I | |||
TSHIX | 15.25 | 0.06 | +0.39% |
Transamerica Multi-Asset Income I | |||
PRHSX | 77.35 | 0.27 | +0.35% |
T. Rowe Price Health Sciences |